Ngā hua rapu

Ngā kaupapa kua whakahuatia i roto i tō rapu.
Whakamahine hua
  1. 1
    Thermodynamic and fibril formation studies of full length immunoglobulin light chain AL-09 and its germline protein using scan rate dependent thermal unfolding

    Thermodynamic and fibril formation studies of full length immunoglobulin light chain AL-09 and its germline protein using scan rate dependent thermal unfolding mā Luis M. Blancas‐Mejía, Tim Horn, Marta Marin‐Argany, Matthew Auton, Alexander Tischer, Marina Ramírez‐Alvarado

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Considerably Unfolded Transthyretin Monomers Preceed and Exchange with Dynamically Structured Amyloid Protofibrils

    Considerably Unfolded Transthyretin Monomers Preceed and Exchange with Dynamically Structured Amyloid Protofibrils mā Minna Groenning, Raúl I. Campos, Daniel Hirschberg, Per Hammarström, Bente Vestergaard

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Amyloid-Forming Properties of Human Apolipoproteins: Sequence Analyses and Structural Insights

    Amyloid-Forming Properties of Human Apolipoproteins: Sequence Analyses and Structural Insights mā Madhurima Das, Olga Gursky

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Primary Nucleation Kinetics of Short Fibril-Forming Amyloidogenic Peptides

    Primary Nucleation Kinetics of Short Fibril-Forming Amyloidogenic Peptides mā Jurriaan A. Luiken, Peter G. Bolhuis

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Chitosan Oligosaccharides Inhibit/Disaggregate Fibrils and Attenuate Amyloid β-Mediated Neurotoxicity

    Chitosan Oligosaccharides Inhibit/Disaggregate Fibrils and Attenuate Amyloid β-Mediated Neurotoxicity mā Xueling Dai, Wanqi Hou, Yaxuan Sun, Zhaolan Gao, Shigong Zhu, Zhao-Feng Jiang

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Finnish hereditary amyloidosis

    Finnish hereditary amyloidosis mā C. P. J. Maury, K. Alii, Marc Baumann

    I whakaputaina 1990
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Biochemical and biophysical features of both oligomer/fibril and cell membrane in amyloid cytotoxicity

    Biochemical and biophysical features of both oligomer/fibril and cell membrane in amyloid cytotoxicity mā Massimo Stefani

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Structural Study of Metastable Amyloidogenic Protein Oligomers by Photo‐Induced Cross‐Linking of Unmodified Proteins

    Structural Study of Metastable Amyloidogenic Protein Oligomers by Photo‐Induced Cross‐Linking of Unmodified Proteins mā Gal Bitan

    I whakaputaina 2006
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Structural prerequisites for serum amyloid A fibril formation.

    Structural prerequisites for serum amyloid A fibril formation. mā M C de Beer, Frederick C. de Beer, William D. McCubbin, C.M. Kay, Mark S. Kindy

    I whakaputaina 1993
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Renal Transplantation in Systemic Amyloidosis—Importance of Amyloid Fibril Type and Precursor Protein Abundance

    Renal Transplantation in Systemic Amyloidosis—Importance of Amyloid Fibril Type and Precursor Protein Abundance mā Jennifer H. Pinney, Helen J. Lachmann, Prayman Sattianayagam, Simon Gibbs, Ashutosh Wechalekar, Christopher P. Venner, Carol Whelan, Janet A. Gilbertson, Dorota Rowczenio, Philip N. Hawkins, Julian D. Gillmore

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Amyloids: Friend or Foe?

    Amyloids: Friend or Foe? mā Neal D. Hammer, Xuan Wang, Bryan A. McGuffie, Matthew R. Chapman

    I whakaputaina 2008
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Mechanisms of amyloid fibril formation – focus on domain‐swapping

    Mechanisms of amyloid fibril formation – focus on domain‐swapping mā Eva Žerovnik, Veronika Stoka, Andreja Mirtič, Gregor Gunčar, Jože Grdadolnik, Rosemary A. Staniforth, Vito Türk, Vito Türk

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    A Routine PET/CT Protocol with Streamlined Calculations for Assessing Cardiac Amyloidosis Using 18F-Florbetapir

    A Routine PET/CT Protocol with Streamlined Calculations for Assessing Cardiac Amyloidosis Using 18F-Florbetapir mā Dustin Osborne, Shelley Acuff, Alan Stuckey, Jonathan S. Wall

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Preparation of Amyloid β‐Protein for Structural and Functional Studies

    Preparation of Amyloid β‐Protein for Structural and Functional Studies mā David B. Teplow

    I whakaputaina 2006
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Insight into Amyloid Structure Using Chemical Probes

    Insight into Amyloid Structure Using Chemical Probes mā Ashley A. Reinke, Jason E. Gestwicki

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Supersaturation-limited and Unlimited Phase Transitions Compete to Produce the Pathway Complexity in Amyloid Fibrillation

    Supersaturation-limited and Unlimited Phase Transitions Compete to Produce the Pathway Complexity in Amyloid Fibrillation mā Masayuki Adachi, Masatomo So, Kazumasa Sakurai, József Kardos, Yuji Goto

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Functional Amyloid Signaling via the Inflammasome, Necrosome, and Signalosome: New Therapeutic Targets in Heart Failure

    Functional Amyloid Signaling via the Inflammasome, Necrosome, and Signalosome: New Therapeutic Targets in Heart Failure mā Traci L. Parry, Jason H. Melehani, Mark J. Ranek, Monte S. Willis

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Angiotensin-converting Enzyme Degrades Alzheimer Amyloid β-Peptide (Aβ); Retards Aβ Aggregation, Deposition, Fibril Formation; and Inhibits Cytotoxicity

    Angiotensin-converting Enzyme Degrades Alzheimer Amyloid β-Peptide (Aβ); Retards Aβ Aggregation, Deposition, Fibril Formation; and Inhibits Cytotoxicity mā Jianguo Hu, Akira Igarashi, Makiko Kamata, Hachiro Nakagawa

    I whakaputaina 2001
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Disrupting Self-Assembly and Toxicity of Amyloidogenic Protein Oligomers by “ Molecular Tweezers” - from the Test Tube to Animal Models

    Disrupting Self-Assembly and Toxicity of Amyloidogenic Protein Oligomers by “ Molecular Tweezers” - from the Test Tube to Animal Models mā Aida Attar, Gal Bitan

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Amino Acid Sequence of an Amyloid Fibril Protein of Unknown Origin

    Amino Acid Sequence of an Amyloid Fibril Protein of Unknown Origin mā Daniel Ein, Shigeru Kimura, William D. Terry, Judith Magnotta, George G. Glenner

    I whakaputaina 1972
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: